Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

Iloperidone

"Subjects will receive oral iloperidone for 8 weeks. The first 2 weeks of treatment is called titration period and during this time the dose of iloperidone will be increased periodically from 1mg to a maximum of 8mg depending on response and tolerability.~During the remaining 6 weeks of treatment, called stable dose period, the subjects will receive a stable dose of iloperidone(defined during titration period)"

DRUG

Placebo

During 8 weeks subjects will receive oral placebo

Trial Locations (1)

80045

University of Colorado Depression Center; Clinical and Translational Research Center (CTRC), Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Colorado, Denver

OTHER